OB/GYN & Women’s Health – Page 6

Reevaluating the Hadlock Estimated Fetal Weight Reference: Implications for Small for Gestational Age Classification

By MedXY 07/01/2026

This analysis highlights significant inconsistencies between chart- and equation-derived centiles in the Hadlock fetal weight reference, revealing the underestimation of small for gestational age fetuses and suggesting recalibration is urgently needed for clinical practice.

news OB/GYN & Women’s Health Oncology

PRO-PLATINUM Trial: Probiotic Modulation of the Microbiome to Enhance Outcomes in Ovarian Cancer Chemotherapy

By MedXY 06/29/2026

The PRO-PLATINUM trial evaluates a novel 5-strain probiotic's effect on gut and vaginal microbiome composition and clinical outcomes in ovarian cancer patients undergoing platinum chemotherapy, assessing safety, feasibility, and translational biomarkers.

news OB/GYN & Women’s Health

Impact of Ring Pessary on Pelvic Anatomy in Upright Position: Insights from Prospective Upright MRI Study

By MedXY 06/28/2026

Upright MRI shows pessary insertion lifts pelvic organs in women with prolapse, with lasting uterine repositioning but transient bladder elevation, informing symptom relief mechanisms.

news OB/GYN & Women’s Health

Unveiling Posttraumatic Stress Trajectories Following Vaginal Delivery: Implications for Early Identification and Intervention

By MedXY 06/28/2026

This multicenter prospective study identifies distinct posttraumatic stress symptom trajectories after vaginal delivery and highlights associated risk factors, providing insights to enhance postpartum PTSD screening and prevention strategies.

news OB/GYN & Women’s Health

Optimizing Postpartum Care: Evaluating High-Dose Oxytocin Infusion to Reduce Blood Loss After Vaginal Delivery

By MedXY 06/28/2026

A quality-improvement study shows that higher prophylactic oxytocin infusion rates after vaginal birth significantly reduce postpartum blood loss and decrease the need for additional uterotonic medications, without increasing transfusion or hemorrhage rates.

Diabetes & Endocrinology news OB/GYN & Women’s Health Orthopedics

Personalizing Osteoporosis Treatment: Integrating Pharmacotherapy with Patient-Centered Lifestyle Strategies

By MedXY 06/28/2026

This article explores personalized osteoporosis management, combining evidence-based pharmacologic therapies with individualized lifestyle and nutrition guidance, to improve patient outcomes through shared decision making.

news OB/GYN & Women’s Health Oncology

Long-Term Outcomes and Durability of Exceptional Responses to PARP Inhibitors in Recurrent Platinum-Sensitive Ovarian Cancer

By MedXY 06/26/2026

This international study reveals that many patients with platinum-sensitive recurrent ovarian cancer achieve durable, progression-free survival exceeding 5 years on PARP inhibitors, even after treatment discontinuation, with a low risk of secondary hematologic malignancies.

news OB/GYN & Women’s Health Pathology & Lab Medicine/Bệnh học

Enhancing Triage of Non-16/18 High-Risk HPV Cervical Lesions Using FAM19A4, SOX1, and PAX1 Methylation Testing

By MedXY 06/25/2026

FAM19A4, SOX1, and PAX1 methylation assays demonstrate high diagnostic accuracy for identifying CIN3+ among non-16/18 hrHPV-positive women, outperforming cytology and reducing unnecessary colposcopies.

news OB/GYN & Women’s Health Public Health

The Impact of Heavy Menstrual Bleeding on Quality of Life: A Mixed-Methods Survey Study

By MedXY 06/25/2026

This study explores how heavy menstrual bleeding affects physical, psychological, social, and functional aspects of life, revealing extensive quality of life impairment beyond just blood loss.

Infectious Diseases news OB/GYN & Women’s Health

Evaluating the Safety of Prenatal RSVpreF Vaccination: Implications for Obstetric and Neonatal Outcomes

By MedXY 06/25/2026

A large-scale VSD study found that prenatal vaccination with bivalent prefusion F RSV vaccine is generally safe, showing no increased risk for preterm birth, stillbirth, or small-for-gestational-age births but a slight increase in hypertensive disorders of pregnancy.

Neurology news OB/GYN & Women’s Health

Influence of Parity on Cognitive Decline and Hippocampal Atrophy in Amyloid-Positive Postmenopausal Women

By MedXY 06/25/2026

Higher parity in cognitively unimpaired postmenopausal women with positive β-amyloid status is linked to accelerated cognitive decline and hippocampal volume reduction, suggesting parity modulates resilience to Alzheimer’s pathology in preclinical stages.

Hematology-Oncology news OB/GYN & Women’s Health

GLP-1 Receptor Agonists May Outperform Bariatric Surgery in Obese Postmenopausal Breast Cancer Patients, Study Suggests

By MedXY 06/18/2026

A large real-world study found GLP-1 receptor agonists were associated with better survival and lower locoregional recurrence than bariatric surgery in postmenopausal women with obesity and breast cancer.

news OB/GYN & Women’s Health Oncology

Prehabilitation During Neoadjuvant Chemotherapy May Improve Surgery Eligibility and Chemotherapy Delivery in Advanced Ovarian Cancer

By MedXY 06/18/2026

A matched-cohort study found that multimodal prehabilitation during neoadjuvant chemotherapy improved chemotherapy delivery and increased the chance of interval debulking surgery in advanced ovarian cancer, with the strongest benefits seen in patients aged 70 and older.

news OB/GYN & Women’s Health Pediatrics

When the Prenatal Ultrasound “Level” Does Not Match the Neurologic Reality: Mapping Anatomical-Motor Discordance in Open Spinal Dysraphism

By MedXY 06/18/2026

In 187 fetuses with open spinal dysraphism, prenatal motor level was more caudal than the anatomical level in 85% of cases, with larger gaps in myeloschisis and higher lesions.

news OB/GYN & Women’s Health Pediatrics

Why the Spinal Lesion Level on Prenatal Ultrasound Often Does Not Match Fetal Motor Function

By MedXY 06/18/2026

Prenatal ultrasound in open spinal dysraphism often underestimates functional level: in 85% of fetuses, motor level was more caudal than anatomy. Lesion type and height influenced the gap, with implications for counseling and fetal care planning.

news OB/GYN & Women’s Health

From Symptoms to Preferences: Q-Methodology Maps What Women With Chronic Pelvic Pain Want From Treatment

By MedXY 06/18/2026

A Q-methodology study translated chronic pelvic pain experiences into five patient preference profiles to better align counseling and treatment selection with what matters most to patients.

Infectious Diseases news OB/GYN & Women’s Health

Hantavirus in Pregnancy: Why Obstetricians Need a High Index of Suspicion

By MedXY 06/17/2026

Hantavirus infection in pregnancy is rare but potentially fatal. Obstetricians should suspect it after rodent or travel exposure, recognize rapid respiratory decline, and prioritize supportive critical care because no proven antiviral therapy exists.

Cardiology news OB/GYN & Women’s Health

Pregnancy-Associated SCAD in Focus: What the iSCAD Registry Reveals About a Rare but High-Stakes Cause of MI in Women

By MedXY 06/15/2026

The iSCAD Registry study highlights distinctive reproductive and psychosocial features among women with pregnancy-associated SCAD, underscoring the need for individualized counseling, heightened diagnostic suspicion, and multidisciplinary follow-up.

news OB/GYN & Women’s Health Oncology

Avelumab Plus Methotrexate in Low-Risk Gestational Trophoblastic Tumors: A Promising First-Line Signal From TROPHAMET

By MedXY 06/15/2026

TROPHAMET found that first-line avelumab plus methotrexate achieved 96.2% hCG normalization in low-risk gestational trophoblastic tumors with manageable toxicity, no relapses at 41 months, and preserved fertility.

news OB/GYN & Women’s Health Oncology

Pelvic Exenteration for Recurrent Cervical Cancer Can Deliver Long-Term Survival, but Survivorship Burden Remains Substantial

By MedXY 06/11/2026

A mixed-methods study suggests pelvic exenteration offers meaningful long-term survival in selected patients with recurrent cervical cancer, while qualitative data reveal persistent physical, social, and sexual burdens that standardized quality-of-life measures may underestimate.